Five things to know:
1. Cardiovascular procedures in outpatient settings are estimated to grow from 10 percent to 30 to 35 percent by the mid-2020s.
2. ASC surgical procedure claims declined nearly 10 percent in 2020, largely because of the COVID-19 pandemic.
3. Total joint replacements at ASCs are expected to grow 95 percent over the next five years.
4. Nearly half of ASC leaders expect revenues to increase in 2021.
5. A nonemergent surgery backlog is expected to continue through 2023.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.